Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
- Baylor College of Medicine, United States
- Howard Hughes Medical Institute, Baylor College of Medicine, United States
- Jan and Dan Duncan Neurological Research Institute, United States
Figures
Figure 1 with 1 supplement
Phenotypic characterization of Fxn-sgRNA mice.
(A) Body size of LacZ- and Fxn-sgRNA mice at P130. Fxn-sgRNA mice exhibit a hunchback phenotype. (B) Hindlimb reflexes of LacZ- and Fxn-sgRNA mice at P130. (C) Rotarod test of LacZ- and Fxn-sgRNA mice at P50 (n = 5) and P130 (n = 6). (D) Wire hang test of LacZ- and Fxn-sgRNA mice at P130. n = 6. Data are presented as mean ± SEM. ***, p<0.001, Student’s t-test.
Figure 1—figure supplement 1
Removal of Fxn using AAV and CRISPR/Cas9.
(A) T7 endonuclease assay to detect Cas9 induced mutations. Red arrows indicate the mismatched genomic Fxn DNA fragments which are cleaved by T7 endonuclease. (B) Immunoblot of FXN protein levels of Neuro-2a cells with LacZ- or Fxn-sgRNA expression. (C) AAV infection efficiency. AAV carrying Fxn-sgRNA with a GFP marker was delivered into the P1 mouse brain. GFP fluorescence indicates cells with AAV infection (green). Nuclei are labeled with DAPI (blue). Scale bar, 50 μm. (D) mRNA levels of Fxn in LacZ- and Fxn-sgRNA mice. Data are presented as mean ± SEM. ***, p<0.001, Student’s t-test.
Figure 2
Loss of Fxn leads to neuronal insults.
(A) Immunostaining of cerebral cortex layer I (top) to VI (bottom) of LacZ- and Fxn-sgRNA mice at P130. ATF3 is labeled in red, and nuclei are marked by Hoechst in blue. n = 3. Quantification is on the right. Scale bar, 50 μm. (B) Immunostaining of cortical neurons of LacZ- and Fxn-sgRNA mice at P130. Axon initial segments are marked by anti-AnkG antibody (green), and ATF3 is marked in red. n = 3. Quantification is on the right. Scale bar, 10 μm. Data are presented as mean ± SEM. **, p<0.01, ***, p<0.001, Student’s t-test.
Figure 3 with 2 supplements
Loss of Fxn leads to an activation of the iron/sphingolipid/PDK1/Mef2 pathway.
(A) Perls’ blue staining with DAB enhancement of the cerebral cortex layer I (top) to VI (bottom) of LacZ- and Fxn-sgRNA mice at P130. n = 3. Scale bar, 100 and 10 μm. (B) RPA and RPAC staining of mouse cortical neurons of LacZ- and Fxn-sgRNA mice at P60. RPA and RPAC fluorescence is in red, and nuclei are labeled by DAPI in green. n = 3. Scale bar: 20 µm. (C) Immunoblot of PDK1 phosphorylation levels of brains of LacZ- and Fxn-sgRNA mice at P60. (D) mRNA levels of Mef2 downstream targets of LacZ- and Fxn-sgRNA mice at P60. n = 3. Data are presented as mean ± SEM. *, p<0.05. **, p<0.01, Student’s t-test.
Figure 3—figure supplement 1
Fe3+ distribution in brains of LacZ- and Fxn-sgRNA mice.
Perls’/DAB staining with neuronal and glial markers of the cerebral cortex of LacZ- and Fxn-sgRNA mice at P130. Neurons are marked by NeuroTrace (red), astrocytes are marked by anti-GFAP antibody (green), and microglia are marked by anti-Iba1 antibody (cyan). DAB signals are marked by circles in other images. Scale bar: 12 µm.
Figure 3—figure supplement 2
Fe3+ staining and immunoblot of LacZ- and Fxn-sgRNA mice.
(A) Perls’ blue staining without DAB enhancement of cerebral cortex layer I (top) to VI (bottom) of LacZ- and Fxn-sgRNA mice at P130. Scale bar: 100 µm. (B) Immunoblot of 4-HNE levels in brain tissues of LacZ- and Fxn-sgRNA mice at P130. (C) Immunoblot of PDK1 levels in brain tissues of LacZ- and Fxn-sgRNA mice at P60.
Figure 4
Sphingolipid levels and PDK1 activity are increased in heart tissues of FRDA patients.
(A) Sphingolipid profiling of heart tissues from controls (n = 5) and FRDA patients (n = 6). Data are presented as mean ± SEM. (B) Immunoblot of PDK1 phosphorylation levels of heart tissues from controls (n = 5) and FRDA patients (n = 6). Box plot of PDK1 phosphorylation is on the right.
Author response image 1
Sphingolipid levels of LacZ- and Fxn-sgRNA mice.
https://doi.org/10.7554/eLife.20732.012Videos
Video 1
LacZ- and Fxn-sgRNA mice at P130.
https://doi.org/10.7554/eLife.20732.004
Video 2
Fxn-sgRNA mice at P130.
https://doi.org/10.7554/eLife.20732.005Tables
Table 1
Clinical and genetic data of 6 FRDA patients.
No. | Gender | Age of onset | Age of death | GAA1 | GAA2 |
|---|---|---|---|---|---|
1 | M | 8 | 27 | 700 | 1070 |
2 | M | 4 | 37 | 674 | 674 |
3 | F | 5 | 25 | 800 | 1100 |
4 | F | 9 | 26 | 690 | 850 |
5 | M | 7 | 35 | 750 | 1100 |
6 | F | 18 | 67 | 621 | 766 |
-
The sizes for two GAA trinucleotide repeat expansions in the first intron of FXN in FRDA patients are shown with the smaller expansion designated GAA1 and the larger expansion designated GAA2.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Loss of Frataxin activates the iron/sphingolipid/PDK1/Mef2 pathway in mammals
eLife 5:e20732.
https://doi.org/10.7554/eLife.20732
